Rights Offering Brings Medivir $41M for Anti-infectives Work March 30, 2010 By Catherine Hollingsworth
Salix's Xifaxan Approved in Liver Failure Patients as Orphan Drug March 26, 2010 By Catherine Hollingsworth
Vernalis' Pain Study Misses its Endpoint; More Studies Unlikely March 25, 2010 By Catherine Hollingsworth
Agennix Brings in $13M to Keep Phase III Cancer Trials Moving March 24, 2010 By Catherine Hollingsworth
Vectura Shares Fall as Novartis Returns Part of Asthma Drug March 24, 2010 By Catherine Hollingsworth
Stimuvax Cancer Trials on Hold Due to a Case of Encephalitis March 24, 2010 By Catherine Hollingsworth Oncothyreon Inc. said that partner Merck Serono has halted clinical trials of Stimuvax after a study patient with multiple myeloma developed inflammation of the brain. (BioWorld Today)Read More
Agennix Brings in $13M to Keep Phase III Cancer Trials Moving March 23, 2010 By Catherine Hollingsworth
Vectura Shares Fall as Novartis Returns Part of Asthma Drug March 19, 2010 By Catherine Hollingsworth
